SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 244.13 |
Enterprise Value ($M) | 238.81 |
Book Value ($M) | 78.93 |
Book Value / Share | 1.48 |
Price / Book | 3.09 |
NCAV ($M) | -1.14 |
NCAV / Share | -0.02 |
Price / NCAV | -213.96 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.31 |
Return on Assets (ROA) | -0.26 |
Return on Equity (ROE) | -0.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.28 |
Current Ratio | 4.76 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 35.28 |
Assets | 115.35 |
Liabilities | 36.42 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 36.68 |
Operating Income | -31.20 |
Net Income | -36.78 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.70 |
Cash from Investing | -7.74 |
Cash from Financing | 12.80 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Telegraph Hill Partners IV, L.P. | 70.80 | 47.21 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
15,118 | 73,181 | 20.66 | |
11,548 | 63,839 | 18.09 | |
12,022 | 76,484 | 15.72 | |
29,675 | 322,328 | 9.21 | |
(click for more detail) |
Similar Companies | |
---|---|
TARA – Protara Therapeutics, Inc. | TBPH – Theravance Biopharma, Inc. |
TCRX – TScan Therapeutics, Inc. | TLPH – Talphera, Inc. |
TNGX – Tango Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io